Skip to content
healthcare.dev
Get a free key

Voraxaze

NDC 50633-210, glucarpidase, injection, powder, for solution, from BTG International Inc..

Product NDC
50633-210
Status
Listed
Labeler
BTG International Inc.
Dosage form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA125327
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50633-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLUCARPIDASE1000 [USP'U]/1

Pharmacologic classes

Carboxypeptidase [EPC]; Carboxypeptidases [CS]

Package NDCNDC-11Package
50633-210-11506330210111 VIAL in 1 CARTON (50633-210-11) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/acaef5a6-b740-40e3-8ffe-74a75c74745c

Use it

Look up 50633-210 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50633-210 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50633-210. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.